BALESTRINO, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 14.637
Totale 14.637
Nazione #
IT - Italia 14.637
Totale 14.637
Città #
Genova 11.104
Rapallo 1.305
Genoa 1.115
Vado Ligure 1.073
Bordighera 40
Totale 14.637
Nome #
Angioedema after rt-PA treatment in acute ischemic stroke may be attended by shock and worsening of stroke outcome 188
A new method to synthesize creatine derivatives. 183
A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity 182
Detection of electrophysiological indicators of neurotoxicity in human and rat brain slices by a three-dimensional microelectrode array. 180
Creatine salts provide neuroprotection even after partial impairment of the creatine transporter 167
Activation of cerebellar granule cells GABAA receptors by guanidinoacetate 165
Protective effects of some creatine derivatives in brain tissue anoxia. 165
Altered Handwriting Suggests Cognitive Impairment and May Be Relevant to Posthumous Evaluation 164
Pathophysiology of pH and Ca2+ in bloodstream and brain. 156
Effects of exogenous creatine on population spike amplitude and on postanoxic hyperexcitability in brain slices. 155
A Novel Method to Synthesize Phosphocreatine and Phosphocreatine Prodrugs 150
Kinetics of creatine in blood and brain after intraperitoneal injection in the rat. 149
Changes in extracellular action potential detect kainic acid and trimethyltin toxicity in hippocampal slice preparations earlier than do MAP2 density measurements 149
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. 148
Creatine ethyl ester: A new substrate for creatine kinase 147
Support of Nerve Conduction by Respiring Myelin Sheath: Role of Connexons. 147
Searching for a therapy of creatine transporter deficiency: some effects of creatine ethyl ester in brain slices in vitro. 146
In vivo neuroprotection by a creatine-derived compound: phosphocreatine-Mg-complex acetate. 143
Di-acetyl creatine ethyl ester, a new creatine derivative for the possible treatment of creatine transporter deficiency 143
Effects on Energy Metabolism of Two Guanidine Molecules, (Boc)2-Creatine and Metformin 143
Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. 142
Blockade of N-methyl-D-aspartate receptor prevents hypoxic neuronal death and cytokine release. 141
Handwriting as a gauge of cognitive status: a novel forensic tool for posthumous evaluation of testamentary capacity 139
Could Mannitol-Induced Delay of Anoxic Depolarization be Relevant in Stroke Patients? 139
Un nuovo parametro grafopatologico nella valutazione dello stato cognitivo: l'indice della scrittura. 139
Seasonal differences and protection by creatine or arginine pretreatment in ischemia of mammalian and molluscan neurons in vitro. 137
Intracerebroventricular administration of creatine protects against damage by global cerebral ischemia in rat 136
Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients 136
Bone marrow-derived progenitor cells in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 135
Effects of Amide Creatine Derivatives in Brain Hippocampal Slices, and Their Possible Usefulness for Curing Creatine Transporter Deficiency. 135
Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices. 131
Validation of a simple method for atrial fibrillation screening in patients with stroke 131
Churg-Strauss syndrome mimicking myocardial infarction with cerebral vascular involvement. 130
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. 130
Neuroprotection by creatine-derived compounds. 129
Structural organization of astrocytes in the rat hippocampus in the post-ischemic period. 126
Biacil creatina carbossil derivata, suoi usi e suo procedimento di sintesi 125
The excitatory amino acid antagonist amino-phosphono-valeric acid (APV) provides protection against penicillin-induced epileptic activity in the rat. 125
Creatine as a Candidate to Prevent Statin Myopathy 124
NMDA antagonists: lack of protective effect against hypoxic damage in CA1 region of hippocampal slices 122
Effects of CO2 and interstitial pH changes on synaptic transmission in CA1 region of rat hippocampus in vitro. 122
The antiepileptic effect of low-dose amino-phosphono-valeric acid (APV) is not enhanced by phosphatidylserine association. 121
Bannwarth syndrome: report of two cases 120
The role of spreading depression-like hypoxic depolarization in irreversible neuron damage, and its prevention 120
Electrophysiological effects of sustained delivery of CRF and its receptor agonists in hippocampal slices. 120
The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds 120
Delirium in the acute phase after stroke: comparison between methods of detection 120
Systemic administration of mesenchymal stem cells increases neuron survival after global cerebral ischemia in vivo (2VO). 120
Spreading depression-like hypoxic depolarization in CA1 and fascia dentata of hippocampal slices: relationship to selective vulnerability 120
Measurements of (Na+, K+)ATPase after in vitro hypoxia and reoxygenation are affected by methods of membrane preparation 118
Complessi di fosfocreatina. 116
Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage 115
The effects of moderate changes of extracellular K+ and Ca2+ on synaptic and neural function in the CA1 region of the hippocampal slice. 113
Controlling the flow of energy: inhibition and stimulation of the creatine transporter. 113
Studies on anoxic depolarization. 112
In vitro study of uptake and synthesis of creatine and its precursors by cerebellar granule cells and astrocytes suggests some hypotheses on the physiopathology of the inherited disorders of creatine metabolism 112
Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development 112
Endovascular treatment for acute ischemic stroke. 111
Concentration of carbon dioxide, interstitial pH and synaptic transmission in hippocampal formation of the rat 111
A method of synthesizing creatine derivatives 109
Thrombolysis for Ischemic Stroke in Patients Aged 90 Years or Older. 108
Biacil carboxy derived creatine, its uses and its synthesis process 108
Uses and abuses of in vitro systems in the study of the pathophysiology of the central nervous system. 107
Applicazione terapeutica di un derivato di creatina 106
Chlorpromazine protects brain tissue in hypoxia by delaying spreading depression-mediated calcium influx. 105
Spreading depression-like depolarization and selective vulnerability of neurons. A brief review. 105
Involvement of S-100 protein in anoxic long-term potentiation. 105
A novel hypothesis about mechanisms affecting conduction velocity of central myelinated fibers. 105
Electrophoretic characterization of gold nanoparticles functionalized with human serum albumin (HSA) and creatine 104
Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship. 102
Abnormalities of Na/K ATPase in migraine with aura 102
Development of vulnerability to hypoxic damage in in vitro hippocampal neurons 101
Advances in the Preclinical Study of Ischemic Stroke 101
Trigeminal neuralgia in pontine ischaemia 101
Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives. 100
Safe and effective outcome of intravenous thrombolysis for acute ischemic stroke in patients aged 90 years or older 100
Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease 100
Advances in the treatment of ischemic stroke. 99
Increase of cerebral phosphocreatine in normal rats after intracerebroventricular administration of creatine 99
Beyond sports: Efficacy and safety of creatine supplementation in pathological or paraphysiological conditions of brain and muscle 98
Statin-induced myopathy prevented by creatine administration 98
Trearments affecting conduction velocity of central myelinated fibers: results and novel hypothesis. 97
Resuming anticoagulation after brain hemorrhage while on warfarin treatment: INR at the time of bleeding should be taken into consideration 97
National Institutes of Health Stroke Scale in patients with primary intracerebral hemorrhage 97
null 96
Malattie cerebrovascolari 96
Block of (Na+,K+)ATPase with ouabain induces spreading depression-like depolarization in hippocampal slices 96
Screening for Fabry disease in patients with ischaemic stroke at young age: the Italian Project on Stroke in Young Adults 96
Prevalence of patent foramen ovale in ischaemic stroke in italy: Results of SISIFO study 96
In vitro neurotoxicology tests based on the coupling of brain slices to silicon microelectrode arrays. 94
Safety and efficacy even after 90 years of age should prompt removal of upper age limits in systemic thrombolysis for stroke 93
Predictors of long-term recurrent vascular events after ischemic stroke at young age: the Italian Project on Stroke in Young Adults. 91
Neuropatia ereditaria da compressione: studio clinico e neurofisiologico di una famiglia 90
Procedimento per sintetizzare derivati della creatina 90
Therapeutic application of a derivative of creatine 89
ENDOTHELIAL DYSFUNCTION IN CADASIL: ROLE OF CIRCULATING PROGENITOR CELLS AND BIO-HUMORAL MARKERS 89
Effects of intravenous infusion of bone marrow stromal cells after global cerebral ischemia 88
Electrophysiological recording of re-aggregating brain cell cultures on multi-electrode arrays to detect acute neurotoxic effects. 88
The neuroprotective effect of creatine in cerebral ischemia. 87
Pathophysiology of anoxic depolarization: new findings and a working hypothesis. 87
Totale 12.058
Categoria #
all - tutte 42.818
article - articoli 36.296
book - libri 524
conference - conferenze 1.381
curatela - curatele 0
other - altro 0
patent - brevetti 2.219
selected - selezionate 0
volume - volumi 2.398
Totale 85.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.837 0 0 0 0 0 407 569 273 344 660 431 153
2020/20211.289 93 107 121 127 79 147 148 100 90 116 92 69
2021/20221.760 65 121 134 209 35 123 119 415 86 149 97 207
2022/20231.593 186 109 19 180 238 275 8 90 284 21 158 25
2023/2024809 53 111 38 93 75 112 70 52 33 14 46 112
2024/20251.155 52 197 75 216 357 258 0 0 0 0 0 0
Totale 14.931